Immunogenicity of GI-4000 vaccine in adjuvant consolidation therapy following definitive treatment in patients with stage I-III adenocarcinoma of the lung with G12C, G12D, or G12V KRAS mutations Meeting Abstract


Authors: D'Angelo, S. P.; Park, B. J.; Krug, L. M.; Crevar, C.; Medina, C. E.; Sumner, D. K.; Richman, J.; Coeshott, C.; Apelian, D.; Cohn, A.; Kris, M. G.; Azzoli, C. G.
Abstract Title: Immunogenicity of GI-4000 vaccine in adjuvant consolidation therapy following definitive treatment in patients with stage I-III adenocarcinoma of the lung with G12C, G12D, or G12V KRAS mutations
Meeting Title: 47th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 29
Issue: 15 Suppl.
Meeting Dates: 2011 Jun 3-7
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2011-05-20
Language: English
ACCESSION: WOS:000208880302209
DOI: 10.1200/jco.2011.29.15_suppl.7070
PROVIDER: wos
Notes: Meeting Abstract: 7070 -- Source: Wos
Altmetric Score
MSK Authors
  1. Lee M Krug
    211 Krug
  2. Christopher G Azzoli
    105 Azzoli
  3. Bernard J Park
    156 Park
  4. Dyana K Sumner
    5 Sumner
  5. Mark Kris
    612 Kris